RetractedArticlePloS one2013

Combination of mTOR and EGFR kinase inhibitors blocks mTORC1 and mTORC2 kinase activity and suppresses the progression of colorectal carcinoma.

Quan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.